Novavax, Inc. Share Price
NVAXNovavax, Inc. Stock Performance
Open $7.23 | Prev. Close $7.39 | Circuit Range N/A |
Day Range $7.23 - $7.66 | Year Range $5.01 - $11.55 | Volume 1,70,439 |
Average Traded $7.52 |
Novavax, Inc. Share Price Chart
About Novavax, Inc.
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Novavax, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Jan-26 | $7.23 | $7.43 | +0.00% |
06-Jan-26 | $7.23 | $7.43 | +2.41% |
05-Jan-26 | $7.12 | $7.25 | +1.54% |
02-Jan-26 | $6.79 | $7.14 | +6.17% |
31-Dec-25 | $6.70 | $6.73 | +0.22% |
30-Dec-25 | $6.76 | $6.71 | -1.54% |
29-Dec-25 | $6.76 | $6.82 | +0.00% |